✦ LIBER ✦

A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative Thais

✍ Scribed by Sorachai Nitayaphan; Chirasak Khamboonruang; Narongrid Sirisophana; Patricia Morgan; Joseph Chiu; Anne-Marie Duliege; Cheodchai Chuenchitra; Thippawan Supapongse; Kittipong Rungruengthanakit; Mark deSouza; John R Mascola; Kit Boggio; Silvia Ratto-Kim; Lauri E Markowitz; Deborah Birx; Vinai Suriyanon; John G McNeil; Arthur E Brown; Rodney A Michael

Book ID: 117433708
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 221 KB
Volume: 18
Category: Article
ISSN: 0264-410X
DOI: 10.1016/s0264-410x(99)00421-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Experiences on recruitment and retention

Experiences on recruitment and retention of volunteers in the first HIV vaccine trial in Dar es Salam, Tanzania - the phase I/II HIVIS 03 trial

✍ Bakari, Muhammad; Munseri, Patricia; Francis, Joel; Aris, Eric; Moshiro, Candida 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 217 KB

Antibody-dependent cell-mediated cytotox

Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX® B/E prime-boost HIV-1 vaccine trial in Thailand

✍ Chitraporn Karnasuta; Robert M. Paris; Josephine H. Cox; Sorachai Nitayaphan; Pu 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 176 KB

A Phase I safety and immunogenicity tria

A Phase I safety and immunogenicity trial of UBI® microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects

✍ John S Lambert; Michael Keefer; Mark J Mulligan; David Schwartz; Jiri Mestecky; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Accelerating clinical development of HIV

Accelerating clinical development of HIV vaccine strategies: methodological challenges and considerations in constructing an optimised multi-arm phase I/II trial design

✍ Richert, Laura; Doussau, Adélaïde; Lelièvre, Jean-Daniel; Arnold, Vincent; Rieux 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 478 KB

First-in-human phase I clinical trial of

First-in-human phase I clinical trial of a recombinant vesicular stomatitis virus (rVSV)-based preventive HIV-1 vaccine

✍ JD Fuchs, I Frank, N Kochar, M Elizaga, M Allen, D Carter, N Frahm… 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 64 KB

Sexual behavior among volunteers enrolle

Sexual behavior among volunteers enrolled in a Phase I HIV vaccine trial: experience of Projet San Francisco in Kigali, Rwanda

✍ J Mukamuyango, E Karita, R Bayingana, J Nyombayire, R Ingabire, S Allen… 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 63 KB